Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers
1 other identifier
observational
600
0 countries
N/A
Brief Summary
This study will recruit nuMoM2b participants to complete autism screening surveys and will identify 200 children with autism and 400 controls for the study. It will then use existing biospecimens to measure pesticides in maternal urine and metabolomic urine and cord blood predictors of autism risk. All data will then be used to build a predictive model for autism risk at the child's birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2025
CompletedFirst Posted
Study publicly available on registry
July 17, 2025
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2028
Study Completion
Last participant's last visit for all outcomes
August 30, 2028
November 21, 2025
November 1, 2025
2 years
June 27, 2025
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnosis of autims
Autism diagnoses will be made using the Autism Diagnostic Inventory on all children who screen positive. Alternatively, if already diagnosed clinically, we will request the diagnostic tool used previously for the child.
The children are age 11-14 currently. The outcome will be measured during contact with the children in the first 18 months of the project.
Interventions
No interventions performed
Eligibility Criteria
children of nuMoM2b cohort
You may qualify if:
- child of nuMoM2b study participant
You may not qualify if:
- no biological samples collected during pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
urine for future use
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
June 27, 2025
First Posted
July 17, 2025
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
August 30, 2028
Study Completion (Estimated)
August 30, 2028
Last Updated
November 21, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After study completion
deidentified data upon request per NIH guidance